University of ChicagoDisclosures
Dr. Davidson has received honoraria related to speaking from Abbott Laboratories, AstraZeneca, GlaxoSmithKline, and Merck & Co. Dr. Davidson has received honoraria related to consulting from Abbott Laboratories, Aegerion, Amgen, AstraZeneca, Atherotech, Daiichi Sankyo, DTC MD, Esperion, GlaxoSmithKline, iMD, Kinemed, LipoScience, Merck & Co., Novo Nordisk, Roche, Sanofi-Aventis, Synarc, Takeda Pharmaceuticals, and Vindico Medical Education. Dr. Davidson has received research grants from Abbott Laboratories, AstraZeneca, Daiichi Sankyo, GlaxoSmithKline, Merck & Co., and Roche. Dr. Davidson serves on the Board of Directors for DTC MD, Omthera, Professional Evaluation Inc., and Sonogene.
|Program Name||Last Air Date||Hosts/Guests|
|Diabetes Cardiovascular Outcomes Trials: What You Need to Know||11/19/2019|
|Biomarkers and Lipidology||03/08/2013|
|Current Inquiries in Lipidology: The NLA's Role in the Field||06/03/2011|
|Predictive Value of Lipid Biomarkers and Inflammatory Markers||05/06/2011|
|Emerging Biomarkers and New Drugs||04/27/2008|
|The Lowdown on Lipid Lowering||11/25/2007|
You need to be logged in to save this episode to a playlist.